ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 3053 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 3053; 2) Community: the network communities that were significantly associated with the response to NSC 3053; 3) Molecule: the relationships between components within communities and NSC 3053; 4) MDR: the compounds that were significantly associated with the NSC 3053.

NSC Compound Enrichment Correlation
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0490935610249067 0.52805132
NSC 303812 Aphidicoline glycinate 0.0490935610249067 0.24943788
NSC 303861 L-Cysteine analog 0.0490935610249067 0.41248034
NSC 30915 Null 0.049093561024907 0.25456149
NSC 339137 PHYSALOLACTONE 0.049093561024907 0.31439606
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.049093561024907 0.31254992
NSC 45236 Null 0.049093561024907 0.21177446
NSC 5332 2-Hydroxy-1-(2-pyridylazo)naphthalene 0.049093561024907 0.050068075
NSC 601518 Null 0.049093561024907 0.35403237
NSC 614887 Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) 0.049093561024907 0.49944296
Total:171  Current:161    [First] [Prev] [Next] [Last]